Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA (COSIRA)
Study to Confirm the Safety and Efficacy of the Reducer on Patients With Refractory Angina
Sponsor: Shockwave Medical, Inc.
A PHASE2 clinical study on Refractory Angina, this trial is completed. The trial is conducted by Shockwave Medical, Inc. and has accumulated 7 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Mar 2025 — Sep 2025 [monthly]
Completed PHASE2
-
Sep 2024 — Mar 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shockwave Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .